Human Normal Immunoglobulin For Subcutaneous Administration

Records for this ingredient, by country (identity only).

ATC — · 1 markets · 70 records

Human Normal Immunoglobulin For Subcutaneous Administration 1 markets · 70 records Forms
Filters
MarketCZ 70

CZ 70 records · 3 shown of 3 Source Státní ústav pro kontrolu léčiv (S · Data as of 2026-11-01

  • 200 mg per mL / per unit basis not statedinjectionCUVITRUHIZENTRA、TAK-881、Xembify
  • 165 mg per mL / per unit basis not statedinjectionCUTAQUIG
  • 100 mg per mL / per unit basis not statedinjectionHYQVIA

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.